Behavioral Therapy for Autism
(M-PRT-IS Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to test a 12-week behavioral program designed to help children with autism who struggle with changes in routine. The treatment, called Modified Pivotal Response Treatment, will be delivered online and involve both parents and children. It suits families in the U.S. with children diagnosed or suspected to have autism, who face significant daily challenges with routine changes. Parents and their children must be able to participate consistently and speak English.
As an unphased trial, this study offers families the opportunity to access innovative support tailored to their needs.
Will I have to stop taking my current medications?
The trial requires that participants have stable medication for at least two weeks with no expected changes, so you can continue taking your current medications as long as they are stable.
What prior data suggests that this behavioral intervention program is safe for youth with autism spectrum disorder?
Research has shown that Pivotal Response Treatment (PRT) is a well-researched therapy for children with Autism Spectrum Disorder (ASD). Studies have found that PRT reduces disruptive behaviors more effectively than other treatments, such as Applied Behavior Analysis (ABA). Based on play, PRT helps improve social communication skills by encouraging children to initiate interactions during play. These studies suggest that PRT is generally safe and well-tolerated for children with ASD.12345
Why are researchers excited about this trial?
Researchers are excited about the modified Pivotal Response Treatment (PRT) for autism because it leverages telehealth to deliver behavioral therapy remotely. Unlike traditional in-person therapies, this approach provides greater accessibility and flexibility for families who may find it challenging to attend frequent, face-to-face sessions. This remote model has the potential to reach a wider audience, making it easier for children with autism to receive consistent treatment from the comfort of their homes. By integrating technology with proven behavioral techniques, this method could revolutionize the way we support and treat children with autism, especially in underserved areas.
What evidence suggests that this behavioral therapy is effective for autism?
Research has shown that Pivotal Response Treatment (PRT) works well for individuals with autism spectrum disorder (ASD). Studies have found that PRT can improve communication and social skills, which are often challenging for those with ASD. PRT targets key areas such as using language to request and respond, and it also helps reduce challenging behaviors. It has effectively brought about positive changes from childhood through adulthood. In this trial, the Modified Pivotal Response Treatment is delivered through a Remote (Telehealth) Intervention Program, providing easy and convenient access for families. Overall, PRT is a well-supported method that may benefit young people with ASD who prefer routines and sameness.26789
Who Is on the Research Team?
Antonio Hardan, MD
Principal Investigator
Stanford University
Are You a Good Fit for This Trial?
This trial is for young people with autism who have a hard time dealing with changes in their routine. They should score high on a specific test for this behavior, be stable on current treatments for two weeks, live in the U.S., and both they and their parents must speak English.Inclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive a 12-week behavioral intervention program delivered via telemedicine, consisting of parent-training and parent-mediated intervention
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Modified Pivotal Response Treatment
Modified Pivotal Response Treatment is already approved in United States, European Union, Canada for the following indications:
- Autism Spectrum Disorder (ASD)
- Insistence on Sameness
- Autism Spectrum Disorder (ASD)
- Autism Spectrum Disorder (ASD)
Find a Clinic Near You
Who Is Running the Clinical Trial?
Stanford University
Lead Sponsor